Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

My pharmacy has been ordered to suspend its licence for 14 days due to a breach. What can and cannot I do during that period?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q447 · Category I: Renewals, changes and penalties for non-compliance (Q401-Q450)
During the 14-day suspension of your licence, your Pharmacy has the same legal status as an unlicensed pharmacy. You must not carry out any activity requiring a licence, including selling any Part I, Part II or Part III poisons; displaying any products containing controlled drug ingredients; or using any title with the meaning of ‘Pharmacy’, ‘dispensary’ or similar. You may clean the shop, take stock, handle administrative work or train staff, but all commercial activities related to the sale of medicines must cease completely.

📘 Regulatory basis

Suspension of a licence means the temporary suspension of licensed status, and all privileges and authorisations based on that licence are temporarily invalid.

📗 Drew Tang's recommendations

We recommend that clients use this period for thorough internal reflection and remediation. Organise all staff to study the relevant regulations, review and revise all work procedures (SOPs), and document all corrective measures in writing, so that you can demonstrate your commitment to improvement and the results achieved to regulators after the suspension period ends.

📕 Risk notice

If you are found secretly continuing to sell medicines during the suspension period, this will be regarded as operating without a licence and will compound the existing disciplinary action. It will almost certainly result in your licence being revoked immediately after the suspension period ends.

Back to Category I: Renewals, Changes and Penalties for Breaches (Q401-Q450) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗